English to Russian Medical Medical: Pharmaceuticals

In this case study, the formation of proteinaceous particles in the CSP in the IV bags was the caused by the dilution of the polysorbate 80 below its protective level.
It was determined that an IV bag protectant (IVBP) pre-treatment of the bag diluent was needed to keep the polysorbate level in the IV bag above the level necessary to mitigate particle formation (above about 0.009%) of the anti-IL6(YTE) antibody clinical sterile preparation (CSP).
The IV bag protectant (IVBP) used was 0.65 % (вес/объем) polysorbate 80 formulated in citrate buffer at pH 6.0 and was added to the bag before anti-IL6(YTE) antibody.

Спасибо!